5. Juli 2024 – With the expiration of COVID-19 Ordinance 3 on 30 June 2024, Swissmedic will no longer grant exceptions for the authorisation and importation of medicinal products for COVID-19 treatment or prevention. During the pandemic, exceptions included rolling authorisations and QR code usage for product information. All previously exempted products now comply with standard therapeutic products legislation.

For more information, see here.